// App-Quantinova.ai

: Azithromycin and Hydroxychloroquine in hospitalized patients with confirmed SARS-CoV-2 infection - a randomized placebo-controlled trial (ProPAC-COVID Trial)

Researchers

Presenter

  • Pradeesh Sivapalan

Principal Investigators

  • Therese Sophie Lapperre

  • Rasmus Dahlin Bojesen

  • Josefin Viktoria Eklöf

  • Andrea Browatzki

  • Jon Torgny Wilcke

  • Vibeke Gottlieb

  • Kjell Erik Julius Håkonsson

  • Casper Tidemandsen

  • Oliver Djurhuus Tupper

  • Howraman Meteran

  • Christina Bergsøe

  • Eva Brøndum

  • Uffe Christian Steinholtz Bødtger

  • Daniel Bech Rasmussen

  • Sidse Graff Jensen

  • Lars Pedersen

  • Alexander Jordan

  • Helene Priemé

  • Christian Søborg

  • Ida E. Steffensen

  • Dorthe Høgsberg

  • Tobias Wirenfeldt Klausen

  • Martin Steen Frydland

  • Peter Lange

  • Asger Sverrild

  • Muzhda Ghanizada

  • Filip Krag Knop

  • Tor Biering-Sørensen

  • Jens D. Lundgren

  • Jens-Ulrik Stæhr Jensen

Medical Centers

  • Dep. of Respiratory Medicine, Næstved-Slagelse-Ringsted Hospitals University of Southern Denmark, Slagelse, Denmark

  • Department of Internal Medicine, Copenhagen University Hospital Herlev, Herlev, Denmark

  • Department of Oncology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark

  • Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

  • Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark

  • Respiratory Medicine Section, Department of Internal Medicine, Herlev-Gentofte Hospital, University of Copenhagen 2. Dep. of Internal Medicine, Zealand University Hospital, Hellerup, Roskilde, Denmark

  • Dep. of Respiratory Medicine, Næstved-Slagelse-Ringsted Hospitals University of Southern Denmark, Slagelse, Denmark

  • Dep. of Respiratory Medicine, Bispebjerg and Frederiksberg Hospital University of Copenhagen, Copenhagen, Denmark

  • Department of Respiratory and Infectious Diseases, Nordsjællands Hospital, University of Copenhagen, Hillerød, Denmark

  • Center for Clinical Metabolic Research, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

  • Dep. of Respiratory Medicine, Amager and Hvidovre Hospital University of Copenhagen, Hvidovre, Denmark

  • CHIP at Department of Infectious Diseases, University of Copenhagen, Copenhagen, Denmark

  • Dep. of Internal Medicine, Zealand University Hospital 2) Dep. of Respiratory Medicine, Næstved-Slagelse-Ringsted Hospitals University of Southern Denmark 3) Institute for Regional Health Research University of Southern Denmark, 1) Roskilde 2) Slagelse 3) Odense, Denmark

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Azithromycin

Outcome

  • N/A


Study Design

  • Randomized

  • Placebo Control

  • Multicenteric

  • Controlled

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A